Page last updated: 2024-08-24

flomoxef and tobramycin

flomoxef has been researched along with tobramycin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasuike, T; Hirai, M; Inoue, T; Misu, K; Nakao, Y; Ohira, H; Ota, K; Tanaka, K; Yamane, T; Yasui, Y1
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R1
Abe, T; Fukuda, M; Hirashima, K; Karasawa, M; Miura, Y; Moriyama, Y; Motoyoshi, K; Nagata, N; Naruse, T; Ninomiya, H; Oh, H; Saito, K; Shibata, A; Shishido, H; Yoshida, M1

Trials

1 trial(s) available for flomoxef and tobramycin

ArticleYear
Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    International journal of hematology, 1999, Volume: 69, Issue:2

    Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Lenograstim; Leukocyte Count; Male; Middle Aged; Neutropenia; Pneumonia; Recombinant Proteins; Tobramycin; Treatment Outcome

1999

Other Studies

2 other study(ies) available for flomoxef and tobramycin

ArticleYear
[Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
    The Japanese journal of antibiotics, 1992, Volume: 45, Issue:8

    Topics: Adult; Aged; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Tobramycin

1992
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin

1991